AzTrials
AzTrials

Attention Deficit/Hyperactivity Disorder(ADHD)NCT07654205

Smartphone-based Intervention for Young Adults With ADHD

A study testing Ecological Momentary Assessment for ADHD and Substance Use - Intervention Group in people with Attention Deficit/Hyperactivity Disorder(ADHD) and Alcohol Use, run by Traci Kennedy at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The primary goal of this clinical trial is to test if a smartphone-based intervention is feasible \& acceptable among young adults with ADHD who also engage in risky drinking behaviors. A secondary aim is to test preliminary intervention efficacy. Read more about this study

Who is it for?
Ages 18 to 25 years
What is being tested?
Ecological Momentary Assessment for ADHD and Substance Use - Intervention Group
Type of treatment
Medical device
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
70 participants
Where
1 siteUnited States
Study dates
15 Jul 2026to 1 May 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 25 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Age 18-25
  • Current diagnosis of Attention Deficit/Hyperactivity Disorder-Combined Type according to the Diagnostic and Statistical Manual of Mental Disorders - Fifth Edition (DSM 5)
  • Drinks at least 4 (for females) / 5 (for males) alcoholic drinks in a single drinking session at least once per week
  • Owns a smartphone
  • Reads and understands English

Who cannot join

  • Currently in high school
  • Actively in treatment for Alcohol Use Disorder

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Traci Kennedy, PhD contact

4122466087

kennedytm2@upmc.edu

Aiden Williard, B.S. contact

4127324911

williarda@upmc.edu

United States1 site, 1 recruiting
  • University of Pittsburgh

    Pittsburgh, Pennsylvania, 15213

    Traci Kennedy, PhD, 4122466087, kennedytm2@upmc.edu

    Aiden Williard, B.S., 4127324911, williarda@upmc.edu

    Recruiting

Other trials in United States

About this study

Official title: Training Inhibitory Control Using Personalized Strategies (TIPS): A Randomized Controlled Feasibility Trial of a Smartphone-Based Intervention for Alcohol Use in Young Adults With ADHD

The primary goal of this clinical trial is to test if a smartphone-based intervention is feasible \& acceptable among young adults with ADHD who also engage in risky drinking behaviors. A secondary aim is to test preliminary intervention efficacy. The main questions it aims to answer are:

Is the smartphone intervention feasible \& acceptable for participants (e.g., are they responding regularly, is there a low level of burden reported)?

Read more

Does the smartphone intervention improve symptom awareness, inhibitory control, and problematic alcohol use?

Participants will:

Attend a virtual baseline visit to assess ADHD, alcohol use, and other life experiences.

Complete either the TIPS smartphone intervention or a control smartphone protocol over the course of 31-days, starting the first Friday after the baseline visit.

Attend a virtual follow-up visit, where many of the same questions from the baseline visit will be asked again.

Being tested
Ecological Momentary Assessment for ADHD and Substance Use - Intervention Group, Ecological Momentary Assessment for ADHD & Substance Use - Control Group
Medical subject headings
Attention Deficit Disorder with Hyperactivity, Alcohol Drinking

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Ecological Momentary Assessment for ADHD and Substance Use - Intervention GroupDevice

    Participants will rate their ADHD symptoms and impairment 4 times daily. Feedback on changes in ADHD symptoms will be provided visually via a graph at each prompt. They will also be texted suggestions following each survey to try behavioral strategies intended to help with their inhibitory control ADHD symptoms and related problems, with a particular focus on alcohol use and problems).

  • Ecological Momentary Assessment for ADHD & Substance Use - Control GroupDevice

    Participants will receive 4 prompts per day in the same time windows as participants in the intervention group. However, participants in the control conditions will not be given the 3 TIPS intervention components (symptom monitoring, symptom feedback, and tailored strategy suggestions) and instead will report about their drinking behaviors. They will also answer several "neutral" questionnaires that have been designed by the study team to keep intervention prompt length similar between groups.

Study groups in NCT07654205
Study groupRoleWhat they receive
Intervention ArmExperimentalParticipants in this arm will be randomly assigned to the Experimental condition of the smartphone portion.
Receives: Device: Ecological Momentary Assessment for ADHD and Substance Use - Intervention Group
Control ArmSham comparatorParticipants in this arm will be randomly assigned to the Control condition of the smartphone portion.
Receives: Device: Ecological Momentary Assessment for ADHD & Substance Use - Control Group

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Average Completion Rate

    Completion rate will be defined as number of surveys completed out of the 124 that will be sent during the 31-day smartphone intervention period. 4 surveys will be sent every day. An average completion rate of 80% in the intervention group would indicate good feasibility.

    Measured: Enrollment to Completion of 31-Day Intervention Period

  2. Average mHealth App Usability Questionnaire (MAUQ) Rating

    The usability of the smartphone intervention will be assessed using the 18-item mHealth App Usability Questionnaire (MAUQ), rated from 1-disagree to 7-agree, with an average of at least 5 indicating good usability.

    Measured: Within 1 month of intervention completion

Secondary outcomes (3)
  1. Change in past-month average alcohol quantity

    A change in past-month average alcohol quantity from pre- to post-intervention, as measured by the 31-day timeline followback interview.

    Measured: Enrollment to Completion of 31-Day Intervention Period,

  2. Change in number of past-month binge-drinking episodes

    A change in number of past-month binge-drinking episodes from pre- to post- intervention, as measured by the timeline followback interview.

    Binge-drinking is defined as drinking 4 or more drinks in assigned female at birth participants, or 5 or more drinks in assigned male at birth participants within a 2-hour period.

    Measured: Enrollment to Completion of 31-Day Intervention Period

  3. Change in number of past-month alcohol problems reported on the Young Adult Alcohol Consequence Questionnaire

    Participants will complete the 23-item Young Adult Alcohol Consequence Questionnaire at baseline (pre-intervention) and follow-up (post-intervention). For each item, participants will indicate whether the item is something they have experienced in the past month.

    Measured: Enrollment to Completion of 31-Day Intervention Period

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Jun 2026
  2. Study start15 Jul 2026
  3. Primary completion1 Mar 2027 (estimated)
  4. Study completion1 May 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
70 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07654205
Sponsor's protocol ID
STUDY25080182
Other IDs
K23AA029133
Status last verified
Jul 2026
First submitted
12 Jun 2026
Last updated
18 Aug 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
Individual data sharing
Yes: All collected IPD will be shared with the National Institute on Alcohol Abuse and Alcoholism Data Archive (NIAAADA). Analytic code may be shared on an open science platform at the time of publication of results.

Publications

  • Kennedy TM, Lee CM, Molina BSG, Pedersen SL. From Assessment to Intervention: Leveraging Ecological Momentary Assessment (EMA) to Develop a Personalized mobile-health (mHealth) Ecological Momentary Intervention (EMI) for Young Adults With ADHD and High-Risk Alcohol Use. J Stud Alcohol Drugs. 2026 Jan;87(1):34-53. doi: 10.15288/jsad.24-00449. Epub 2025 Aug 29.

    PubMed 40880228

Questions about this trial

What is this clinical trial studying?

A study testing Ecological Momentary Assessment for ADHD and Substance Use - Intervention Group in people with Attention Deficit/Hyperactivity Disorder(ADHD) and Alcohol Use, run by Traci Kennedy at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 18 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Traci Kennedy, PhD (4122466087, kennedytm2@upmc.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Average Completion Rate (time frame: Enrollment to Completion of 31-Day Intervention Period). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07654205, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Aug 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in